Septic shock in bacteremic patients: Risk factors, features and prognosis

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 1, 1997, Pages 71-75

  Leibovici, Leonard ^a   Drucker, Moshe ^a   Konigsberger, Hanna ^a   Samra, Zmira ^a   Harrari, Schlomit ^b   Ashkenazi, Shai ^a   Pitlik, Silvio D ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CHILD; FEMALE; HUMAN; INFANT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; SEPTIC SHOCK;

EID: 0030946482     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709008668     Document Type: Article

References (22)

1. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fimgemia. JAMA 274: 807-812, 1995.
2. Weinstein MP, Relier LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5: 35-53, 1983.
3. Gatell JM, Trilla A, Latorre X, Almela M, Mensa J, Moreno A, Miro JM, Martinez JA, Jimenez de Anta MT, Soriano E, Garcia San Miguel J. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis 10: 203-210, 1988.
4. Leibovici L, Konisberger H, Pitlik SD, Samra Z, Drucker M. Bacteremia and fungemia of unknown origin in adults. Clin Infect Dis 14: 436-443, 1992.
5. Aube H, Milan C, Blettery B. Risk-factors for septic shock in the early management of bacteremia. Am J Med 93: 283-288, 1992.
6. Rackow EC, Astiz ME. Pathophysiology and treatment of septic shock. JAMA 266: 548-554, 1991.
7. Warren HS, Danner RL, Munford RS. Anti-endotoxin monoclonal antibodies. N Engl J Med 326: 1153-1157, 1992.
8. Cross AS. Anti-endotoxin antibodies: a dead end? Ann Intern Med 121: 58-60, 1994.
9. Natanson C. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120: 771-783, 1994.
10. Wolff S. Biological effects of bacterial endotoxins in man. J Infect Dis 128: S259-S64, 1973.
11. Suffredini A, Fromm R, Parker M, Brenner M, Kovacs JA, Wesley RA, Parrilo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321: 280-286, 1989.
12. Bone RC. Gram-positive organisms and sepsis. Arch Intern Med 154: 26-34, 1994.
13. Bamberger DM, Gurley MB. Microbiological etiology and clinical characteristics of distributive shock. Clin Infect Dis 18: 726-730, 1994.
14. Bone RC. Why sepsis trials fail. JAMA 276: 565-566, 1996.
15. The LOGISTIC procedure. In: SAS/STAT User's Guide, version 6, 4th edition, vol. 2. Cary, NC: SAS Institute Inc., 1071-1126, 1990.
16. Leibovici L, Greenshtain S, Cohen O, Mor F, Wysenbeek AJ. Bacteremia in febrile patients: a clinical model for diagnosis. Arch Intern Med 151: 1801-1806, 1991. '17. Pompei P, Charlson ME, Ales K, MacKenzie CR, Norton M. Relating patients characteristics at the time of admission to outcomes of hospitalization. J Clin Epidemiol 44: 1063-1069, 1991.
17. Corti M-C, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older patients. JAMA 272: 1036-1042, 1994.
18. Deysine M, Liwblich N, Aufsen HA. Albumin changes during clinical septic shock. Surg Gynecol Obstet 173: 474-478, 1973.
19. Holcroft JW, Trunkey DD, Carpenter MA. Extravasation of albumin in tissues of normal and septic baboons and sheep. J Surg Res 26: 341-347, 1979.
20. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer and other causes. Lancet 2: 1434-1436, 1989.
21. Weinstein MP, Murphy JR, Relier LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 5: 54-70, 1983.
22. Leibovici L, Pitlik SD, Konisberger H, Drucker M. Bloodstream infections in patients older than eighty years. Age Ageing 22: 431-442